EU watchdog reiterates caution on hydroxychloroquine use in COVID-19 patients

Healthcare professionals should closely monitor COVID-19 patients who are receiving malaria drug hydroxychloroquine, given the serious side effects associated with the medicine, the European health regulator said on Friday.